Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Hanson Wade to hold a virtual summit » 04:55
09/02/21
09/02
04:55
09/02/21
04:55
SANA

Sana Biotechnology

$24.69 /

+0.69 (+2.88%)

, ACET

Adicet Bio

$8.28 /

-0.05 (-0.60%)

, ACN

Accenture

$337.93 /

+1.48 (+0.44%)

, ADAP

Adaptimmune

$5.05 /

-0.1 (-1.94%)

, ALLO

Allogene Therapeutics

$24.77 /

+0.99 (+4.16%)

, AMGN

Amgen

$223.36 /

-2.16 (-0.96%)

, BMY

Bristol-Myers

$65.81 /

-1.05 (-1.57%)

, CDNA

CareDx

$75.47 /

+2.27 (+3.10%)

, CRBU

Caribou Biosciences

$27.01 /

-0.155 (-0.57%)

, CLLS

Cellectis

$14.89 /

+0.46 (+3.19%)

, TALS

Talaris Therapeutics

$12.20 /

+0.55 (+4.72%)

, TAK

Takeda Pharmaceutical

$16.91 /

+0.32 (+1.93%)

, SYNH

Syneos Health

$93.44 /

+0.71 (+0.77%)

, SGMO

Sangamo

$10.22 /

+0.31 (+3.13%)

, RHHBY

Roche

$49.94 /

-0.28 (-0.56%)

, NVS

Novartis

$92.66 /

+0.26 (+0.28%)

, FATE

Fate Therapeutics

$75.32 /

+2.05 (+2.80%)

, GSK

GlaxoSmithKline

$41.10 /

+0.36 (+0.88%)

, JNJ

Johnson & Johnson

$173.71 /

+0.6 (+0.35%)

, LEGN

Legend Biotech

$38.66 /

+0.45 (+1.18%)

, MRK

Merck

$76.19 /

-0.11 (-0.14%)

, MRKR

Marker Therapeutics

$1.96 /

-0.02 (-1.01%)

6th Annual CAR-TCR…

6th Annual CAR-TCR Virtual Summit will be held on August 30-September 2.Webcast Link

ShowHide Related Items >><<
TALS Talaris Therapeutics
$12.20 /

+0.55 (+4.72%)

TAK Takeda Pharmaceutical
$16.91 /

+0.32 (+1.93%)

SYNH Syneos Health
$93.44 /

+0.71 (+0.77%)

SGMO Sangamo
$10.22 /

+0.31 (+3.13%)

SANA Sana Biotechnology
$24.69 /

+0.69 (+2.88%)

RHHBY Roche
$49.94 /

-0.28 (-0.56%)

NVS Novartis
$92.66 /

+0.26 (+0.28%)

MRKR Marker Therapeutics
$1.96 /

-0.02 (-1.01%)

MRK Merck
$76.19 /

-0.11 (-0.14%)

LEGN Legend Biotech
$38.66 /

+0.45 (+1.18%)

JNJ Johnson & Johnson
$173.71 /

+0.6 (+0.35%)

GSK GlaxoSmithKline
$41.10 /

+0.36 (+0.88%)

FATE Fate Therapeutics
$75.32 /

+2.05 (+2.80%)

CRBU Caribou Biosciences
$27.01 /

-0.155 (-0.57%)

CLLS Cellectis
$14.89 /

+0.46 (+3.19%)

CDNA CareDx
$75.47 /

+2.27 (+3.10%)

BMY Bristol-Myers
$65.81 /

-1.05 (-1.57%)

AMGN Amgen
$223.36 /

-2.16 (-0.96%)

ALLO Allogene Therapeutics
$24.77 /

+0.99 (+4.16%)

ADAP Adaptimmune
$5.05 /

-0.1 (-1.94%)

ACN Accenture
$337.93 /

+1.48 (+0.44%)

ACET Adicet Bio
$8.28 /

-0.05 (-0.60%)

SANA Sana Biotechnology
$24.69 /

+0.69 (+2.88%)

03/01/21 Morgan Stanley
Sana Biotechnology initiated with an Overweight at Morgan Stanley
03/01/21 JPMorgan
Sana Biotechnology initiated with a Neutral at JPMorgan
03/01/21 BofA
Sana Biotechnology initiated with a Buy at BofA
03/01/21 Goldman Sachs
Sana Biotechnology initiated with a Neutral at Goldman Sachs
ACET Adicet Bio
$8.28 /

-0.05 (-0.60%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
ACN Accenture
$337.93 /

+1.48 (+0.44%)

08/17/21 JPMorgan
Accenture price target raised to $364 from $308 at JPMorgan
07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
ADAP Adaptimmune
$5.05 /

-0.1 (-1.94%)

05/28/21 Barclays
Adaptimmune initiated with an Underweight at Barclays
ALLO Allogene Therapeutics
$24.77 /

+0.99 (+4.16%)

08/06/21 B. Riley
Allogene Therapeutics price target lowered to $40 from $52 at B. Riley
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
AMGN Amgen
$223.36 /

-2.16 (-0.96%)

08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
08/04/21 Piper Sandler
Amgen Q2 'good enough' to avoid share selloff, says Piper Sandler
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 SVB Leerink
Amgen price target raised to $238 from $230 at SVB Leerink
BMY Bristol-Myers
$65.81 /

-1.05 (-1.57%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
CDNA CareDx
$75.47 /

+2.27 (+3.10%)

08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
07/30/21 Piper Sandler
CareDx price target raised to $110 from $100 at Piper Sandler
07/20/21
Fly Intel: Top five analyst initiations
07/20/21 BTIG
CareDx assumed with a Buy at BTIG
CRBU Caribou Biosciences
$27.01 /

-0.155 (-0.57%)

08/17/21
Fly Intel: Top five analyst initiations
08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
CLLS Cellectis
$14.89 /

+0.46 (+3.19%)

04/28/21 Guggenheim
Cellectis downgraded to Neutral on slow progress at Guggenheim
04/28/21 Guggenheim
Cellectis downgraded to Neutral from Buy at Guggenheim
03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
TALS Talaris Therapeutics
$12.20 /

+0.55 (+4.72%)

06/01/21 SVB Leerink
Talaris Therapeutics initiated with an Outperform at SVB Leerink
06/01/21 Evercore ISI
Evercore starts Talaris Therapeutics at Outperform with $35 price target
06/01/21 Evercore ISI
Talaris Therapeutics initiated with an Outperform at Evercore ISI
06/01/21 Guggenheim
Talaris Therapeutics initiated with a Buy at Guggenheim
TAK Takeda Pharmaceutical
$16.91 /

+0.32 (+1.93%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
SYNH Syneos Health
$93.44 /

+0.71 (+0.77%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
SGMO Sangamo
$10.22 /

+0.31 (+3.13%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RHHBY Roche
$49.94 /

-0.28 (-0.56%)

08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
07/23/21 Barclays
Roche price target raised to CHF 395 from CHF 375 at Barclays
07/22/21 UBS
Roche price target raised to CHF 375 from CHF 330 at UBS
NVS Novartis
$92.66 /

+0.26 (+0.28%)

07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/22/21 Deutsche Bank
Novartis downgraded to Hold from Buy at Deutsche Bank
07/12/21 SVB Leerink
Molecular Partners assumed with an Outperform at SVB Leerink
FATE Fate Therapeutics
$75.32 /

+2.05 (+2.80%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
GSK GlaxoSmithKline
$41.10 /

+0.36 (+0.88%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
08/18/21 Wedbush
AnaptysBio price target raised to $25 from $20 at Wedbush
JNJ Johnson & Johnson
$173.71 /

+0.6 (+0.35%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
LEGN Legend Biotech
$38.66 /

+0.45 (+1.18%)

06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
MRK Merck
$76.19 /

-0.11 (-0.14%)

08/25/21 H.C. Wainwright
Ligand gets royalty on sales of Merck's Vaxneuvance, says H.C. Wainwright
07/26/21 Truist
Merck assumed with a Buy at Truist
07/26/21 Truist
Merck assumed with a Buy at Truist
07/02/21 Mizuho
Merck gastric cancer withdrawal not meaningful, says Mizuho
MRKR Marker Therapeutics
$1.96 /

-0.02 (-1.01%)

03/25/21 Piper Sandler
Marker Therapeutics initiated with an Overweight at Piper Sandler
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Cantor Fitzgerald
Cantor Fitzgerald starts 'undervalued' Marker Therapeutics at Overweight
03/18/21 Cantor Fitzgerald
Marker Therapeutics initiated with an Overweight at Cantor Fitzgerald
TALS Talaris Therapeutics
$12.20 /

+0.55 (+4.72%)

TAK Takeda Pharmaceutical
$16.91 /

+0.32 (+1.93%)

SYNH Syneos Health
$93.44 /

+0.71 (+0.77%)

SGMO Sangamo
$10.22 /

+0.31 (+3.13%)

SANA Sana Biotechnology
$24.69 /

+0.69 (+2.88%)

RHHBY Roche
$49.94 /

-0.28 (-0.56%)

NVS Novartis
$92.66 /

+0.26 (+0.28%)

MRKR Marker Therapeutics
$1.96 /

-0.02 (-1.01%)

MRK Merck
$76.19 /

-0.11 (-0.14%)

LEGN Legend Biotech
$38.66 /

+0.45 (+1.18%)

JNJ Johnson & Johnson
$173.71 /

+0.6 (+0.35%)

GSK GlaxoSmithKline
$41.10 /

+0.36 (+0.88%)

FATE Fate Therapeutics
$75.32 /

+2.05 (+2.80%)

CLLS Cellectis
$14.89 /

+0.46 (+3.19%)

CDNA CareDx
$75.47 /

+2.27 (+3.10%)

BMY Bristol-Myers
$65.81 /

-1.05 (-1.57%)

AMGN Amgen
$223.36 /

-2.16 (-0.96%)

ALLO Allogene Therapeutics
$24.77 /

+0.99 (+4.16%)

ADAP Adaptimmune
$5.05 /

-0.1 (-1.94%)

ACN Accenture
$337.93 /

+1.48 (+0.44%)

ACET Adicet Bio
$8.28 /

-0.05 (-0.60%)

  • 23
    Jul
  • 03
    Jun
  • 04
    May
  • 07
    May
  • 12
    Mar
  • 01
    Mar
  • 10
    Feb
  • 04
    Feb
  • 21
    Jan
  • 06
    Jan
  • 16
    Dec
  • 02
    Dec
  • 24
    Sep
  • 16
    Sep
TAK Takeda Pharmaceutical
$16.91 /

+0.32 (+1.93%)

SYNH Syneos Health
$93.44 /

+0.71 (+0.77%)

RHHBY Roche
$49.94 /

-0.28 (-0.56%)

NVS Novartis
$92.66 /

+0.26 (+0.28%)

MRK Merck
$76.19 /

-0.11 (-0.14%)

JNJ Johnson & Johnson
$173.71 /

+0.6 (+0.35%)

GSK GlaxoSmithKline
$41.10 /

+0.36 (+0.88%)

BMY Bristol-Myers
$65.81 /

-1.05 (-1.57%)

ACN Accenture
$337.93 /

+1.48 (+0.44%)

TALS Talaris Therapeutics
$12.20 /

+0.55 (+4.72%)

TAK Takeda Pharmaceutical
$16.91 /

+0.32 (+1.93%)

RHHBY Roche
$49.94 /

-0.28 (-0.56%)

NVS Novartis
$92.66 /

+0.26 (+0.28%)

MRKR Marker Therapeutics
$1.96 /

-0.02 (-1.01%)

MRK Merck
$76.19 /

-0.11 (-0.14%)

LEGN Legend Biotech
$38.66 /

+0.45 (+1.18%)

JNJ Johnson & Johnson
$173.71 /

+0.6 (+0.35%)

GSK GlaxoSmithKline
$41.10 /

+0.36 (+0.88%)

FATE Fate Therapeutics
$75.32 /

+2.05 (+2.80%)

CRBU Caribou Biosciences
$27.01 /

-0.155 (-0.57%)

CDNA CareDx
$75.47 /

+2.27 (+3.10%)

BMY Bristol-Myers
$65.81 /

-1.05 (-1.57%)

AMGN Amgen
$223.36 /

-2.16 (-0.96%)

ALLO Allogene Therapeutics
$24.77 /

+0.99 (+4.16%)

ADAP Adaptimmune
$5.05 /

-0.1 (-1.94%)

ACN Accenture
$337.93 /

+1.48 (+0.44%)

ACET Adicet Bio
$8.28 /

-0.05 (-0.60%)

TAK Takeda Pharmaceutical
$16.91 /

+0.32 (+1.93%)

SANA Sana Biotechnology
$24.69 /

+0.69 (+2.88%)

MRK Merck
$76.19 /

-0.11 (-0.14%)

JNJ Johnson & Johnson
$173.71 /

+0.6 (+0.35%)

GSK GlaxoSmithKline
$41.10 /

+0.36 (+0.88%)

BMY Bristol-Myers
$65.81 /

-1.05 (-1.57%)

AMGN Amgen
$223.36 /

-2.16 (-0.96%)

ACN Accenture
$337.93 /

+1.48 (+0.44%)

ACET Adicet Bio
$8.28 /

-0.05 (-0.60%)

Conference/Events
Hanson Wade to hold a virtual summit » 04:55
09/01/21
09/01
04:55
09/01/21
04:55
SANA

Sana Biotechnology

$24.00 /

+0.12 (+0.50%)

, ACET

Adicet Bio

$8.33 /

+0.32 (+4.00%)

, ACN

Accenture

$336.52 /

-0.43 (-0.13%)

, ADAP

Adaptimmune

$5.16 /

-0.06 (-1.15%)

, ALLO

Allogene Therapeutics

$23.84 /

-0.31 (-1.28%)

, AMGN

Amgen

$225.54 /

+1.4 (+0.62%)

, BMY

Bristol-Myers

$66.86 /

-0.35 (-0.52%)

, CDNA

CareDx

$73.17 /

-7.31 (-9.08%)

, CRBU

Caribou Biosciences

$27.20 /

+2.7 (+11.02%)

, CLLS

Cellectis

$14.38 /

+0.4301 (+3.08%)

, TALS

Talaris Therapeutics

$11.65 /

-0.39 (-3.24%)

, TAK

Takeda Pharmaceutical

$16.59 /

+0.035 (+0.21%)

, SYNH

Syneos Health

$92.76 /

-0.78 (-0.83%)

, SGMO

Sangamo

$9.91 /

+0.03 (+0.30%)

, RHHBY

Roche

$50.22 /

+0.47 (+0.94%)

, NVS

Novartis

$92.40 /

+0.73 (+0.80%)

, FATE

Fate Therapeutics

$73.27 /

+1.54 (+2.15%)

, GSK

GlaxoSmithKline

$40.74 /

-0.18 (-0.44%)

, JNJ

Johnson & Johnson

$173.11 /

-0.56 (-0.32%)

, LEGN

Legend Biotech

$38.21 /

+0.21 (+0.55%)

, MRK

Merck

$76.28 /

-0.23 (-0.30%)

, MRKR

Marker Therapeutics

$1.98 /

+0.08 (+4.21%)

6th Annual CAR-TCR…

6th Annual CAR-TCR Virtual Summit will be held on August 30-September 2.Webcast Link

ShowHide Related Items >><<
TALS Talaris Therapeutics
$11.65 /

-0.39 (-3.24%)

TAK Takeda Pharmaceutical
$16.59 /

+0.035 (+0.21%)

SYNH Syneos Health
$92.76 /

-0.78 (-0.83%)

SGMO Sangamo
$9.91 /

+0.03 (+0.30%)

SANA Sana Biotechnology
$24.00 /

+0.12 (+0.50%)

RHHBY Roche
$50.22 /

+0.47 (+0.94%)

NVS Novartis
$92.40 /

+0.73 (+0.80%)

MRKR Marker Therapeutics
$1.98 /

+0.08 (+4.21%)

MRK Merck
$76.28 /

-0.23 (-0.30%)

LEGN Legend Biotech
$38.21 /

+0.21 (+0.55%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSK GlaxoSmithKline
$40.74 /

-0.18 (-0.44%)

FATE Fate Therapeutics
$73.27 /

+1.54 (+2.15%)

CRBU Caribou Biosciences
$27.20 /

+2.7 (+11.02%)

CLLS Cellectis
$14.38 /

+0.4301 (+3.08%)

CDNA CareDx
$73.17 /

-7.31 (-9.08%)

BMY Bristol-Myers
$66.86 /

-0.35 (-0.52%)

AMGN Amgen
$225.54 /

+1.4 (+0.62%)

ALLO Allogene Therapeutics
$23.84 /

-0.31 (-1.28%)

ADAP Adaptimmune
$5.16 /

-0.06 (-1.15%)

ACN Accenture
$336.52 /

-0.43 (-0.13%)

ACET Adicet Bio
$8.33 /

+0.32 (+4.00%)

SANA Sana Biotechnology
$24.00 /

+0.12 (+0.50%)

03/01/21 Morgan Stanley
Sana Biotechnology initiated with an Overweight at Morgan Stanley
03/01/21 JPMorgan
Sana Biotechnology initiated with a Neutral at JPMorgan
03/01/21 BofA
Sana Biotechnology initiated with a Buy at BofA
03/01/21 Goldman Sachs
Sana Biotechnology initiated with a Neutral at Goldman Sachs
ACET Adicet Bio
$8.33 /

+0.32 (+4.00%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
ACN Accenture
$336.52 /

-0.43 (-0.13%)

08/17/21 JPMorgan
Accenture price target raised to $364 from $308 at JPMorgan
07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
ADAP Adaptimmune
$5.16 /

-0.06 (-1.15%)

05/28/21 Barclays
Adaptimmune initiated with an Underweight at Barclays
ALLO Allogene Therapeutics
$23.84 /

-0.31 (-1.28%)

08/06/21 B. Riley
Allogene Therapeutics price target lowered to $40 from $52 at B. Riley
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
AMGN Amgen
$225.54 /

+1.4 (+0.62%)

08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
08/04/21 Piper Sandler
Amgen Q2 'good enough' to avoid share selloff, says Piper Sandler
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 SVB Leerink
Amgen price target raised to $238 from $230 at SVB Leerink
BMY Bristol-Myers
$66.86 /

-0.35 (-0.52%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
CDNA CareDx
$73.17 /

-7.31 (-9.08%)

08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
07/30/21 Piper Sandler
CareDx price target raised to $110 from $100 at Piper Sandler
07/20/21
Fly Intel: Top five analyst initiations
07/20/21 BTIG
CareDx assumed with a Buy at BTIG
CRBU Caribou Biosciences
$27.20 /

+2.7 (+11.02%)

08/17/21
Fly Intel: Top five analyst initiations
08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
CLLS Cellectis
$14.38 /

+0.4301 (+3.08%)

04/28/21 Guggenheim
Cellectis downgraded to Neutral on slow progress at Guggenheim
04/28/21 Guggenheim
Cellectis downgraded to Neutral from Buy at Guggenheim
03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
TALS Talaris Therapeutics
$11.65 /

-0.39 (-3.24%)

06/01/21 SVB Leerink
Talaris Therapeutics initiated with an Outperform at SVB Leerink
06/01/21 Evercore ISI
Evercore starts Talaris Therapeutics at Outperform with $35 price target
06/01/21 Evercore ISI
Talaris Therapeutics initiated with an Outperform at Evercore ISI
06/01/21 Guggenheim
Talaris Therapeutics initiated with a Buy at Guggenheim
TAK Takeda Pharmaceutical
$16.59 /

+0.035 (+0.21%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
SYNH Syneos Health
$92.76 /

-0.78 (-0.83%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
SGMO Sangamo
$9.91 /

+0.03 (+0.30%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RHHBY Roche
$50.22 /

+0.47 (+0.94%)

08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
07/23/21 Barclays
Roche price target raised to CHF 395 from CHF 375 at Barclays
07/22/21 UBS
Roche price target raised to CHF 375 from CHF 330 at UBS
NVS Novartis
$92.40 /

+0.73 (+0.80%)

07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/22/21 Deutsche Bank
Novartis downgraded to Hold from Buy at Deutsche Bank
07/12/21 SVB Leerink
Molecular Partners assumed with an Outperform at SVB Leerink
FATE Fate Therapeutics
$73.27 /

+1.54 (+2.15%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
GSK GlaxoSmithKline
$40.74 /

-0.18 (-0.44%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
08/18/21 Wedbush
AnaptysBio price target raised to $25 from $20 at Wedbush
JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
LEGN Legend Biotech
$38.21 /

+0.21 (+0.55%)

06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
MRK Merck
$76.28 /

-0.23 (-0.30%)

08/25/21 H.C. Wainwright
Ligand gets royalty on sales of Merck's Vaxneuvance, says H.C. Wainwright
07/26/21 Truist
Merck assumed with a Buy at Truist
07/26/21 Truist
Merck assumed with a Buy at Truist
07/02/21 Mizuho
Merck gastric cancer withdrawal not meaningful, says Mizuho
MRKR Marker Therapeutics
$1.98 /

+0.08 (+4.21%)

03/25/21 Piper Sandler
Marker Therapeutics initiated with an Overweight at Piper Sandler
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Cantor Fitzgerald
Cantor Fitzgerald starts 'undervalued' Marker Therapeutics at Overweight
03/18/21 Cantor Fitzgerald
Marker Therapeutics initiated with an Overweight at Cantor Fitzgerald
TALS Talaris Therapeutics
$11.65 /

-0.39 (-3.24%)

TAK Takeda Pharmaceutical
$16.59 /

+0.035 (+0.21%)

SYNH Syneos Health
$92.76 /

-0.78 (-0.83%)

SGMO Sangamo
$9.91 /

+0.03 (+0.30%)

SANA Sana Biotechnology
$24.00 /

+0.12 (+0.50%)

RHHBY Roche
$50.22 /

+0.47 (+0.94%)

NVS Novartis
$92.40 /

+0.73 (+0.80%)

MRKR Marker Therapeutics
$1.98 /

+0.08 (+4.21%)

MRK Merck
$76.28 /

-0.23 (-0.30%)

LEGN Legend Biotech
$38.21 /

+0.21 (+0.55%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSK GlaxoSmithKline
$40.74 /

-0.18 (-0.44%)

FATE Fate Therapeutics
$73.27 /

+1.54 (+2.15%)

CLLS Cellectis
$14.38 /

+0.4301 (+3.08%)

CDNA CareDx
$73.17 /

-7.31 (-9.08%)

BMY Bristol-Myers
$66.86 /

-0.35 (-0.52%)

AMGN Amgen
$225.54 /

+1.4 (+0.62%)

ALLO Allogene Therapeutics
$23.84 /

-0.31 (-1.28%)

ADAP Adaptimmune
$5.16 /

-0.06 (-1.15%)

ACN Accenture
$336.52 /

-0.43 (-0.13%)

ACET Adicet Bio
$8.33 /

+0.32 (+4.00%)

  • 23
    Jul
  • 03
    Jun
  • 04
    May
  • 07
    May
  • 12
    Mar
  • 01
    Mar
  • 10
    Feb
  • 04
    Feb
  • 21
    Jan
  • 06
    Jan
  • 16
    Dec
  • 02
    Dec
  • 24
    Sep
  • 16
    Sep
TAK Takeda Pharmaceutical
$16.59 /

+0.035 (+0.21%)

SYNH Syneos Health
$92.76 /

-0.78 (-0.83%)

RHHBY Roche
$50.22 /

+0.47 (+0.94%)

NVS Novartis
$92.40 /

+0.73 (+0.80%)

MRK Merck
$76.28 /

-0.23 (-0.30%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSK GlaxoSmithKline
$40.74 /

-0.18 (-0.44%)

BMY Bristol-Myers
$66.86 /

-0.35 (-0.52%)

ACN Accenture
$336.52 /

-0.43 (-0.13%)

TALS Talaris Therapeutics
$11.65 /

-0.39 (-3.24%)

TAK Takeda Pharmaceutical
$16.59 /

+0.035 (+0.21%)

RHHBY Roche
$50.22 /

+0.47 (+0.94%)

NVS Novartis
$92.40 /

+0.73 (+0.80%)

MRKR Marker Therapeutics
$1.98 /

+0.08 (+4.21%)

MRK Merck
$76.28 /

-0.23 (-0.30%)

LEGN Legend Biotech
$38.21 /

+0.21 (+0.55%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSK GlaxoSmithKline
$40.74 /

-0.18 (-0.44%)

FATE Fate Therapeutics
$73.27 /

+1.54 (+2.15%)

CRBU Caribou Biosciences
$27.20 /

+2.7 (+11.02%)

CDNA CareDx
$73.17 /

-7.31 (-9.08%)

BMY Bristol-Myers
$66.86 /

-0.35 (-0.52%)

AMGN Amgen
$225.54 /

+1.4 (+0.62%)

ALLO Allogene Therapeutics
$23.84 /

-0.31 (-1.28%)

ADAP Adaptimmune
$5.16 /

-0.06 (-1.15%)

ACN Accenture
$336.52 /

-0.43 (-0.13%)

ACET Adicet Bio
$8.33 /

+0.32 (+4.00%)

TAK Takeda Pharmaceutical
$16.59 /

+0.035 (+0.21%)

SANA Sana Biotechnology
$24.00 /

+0.12 (+0.50%)

MRK Merck
$76.28 /

-0.23 (-0.30%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSK GlaxoSmithKline
$40.74 /

-0.18 (-0.44%)

BMY Bristol-Myers
$66.86 /

-0.35 (-0.52%)

AMGN Amgen
$225.54 /

+1.4 (+0.62%)

ACN Accenture
$336.52 /

-0.43 (-0.13%)

ACET Adicet Bio
$8.33 /

+0.32 (+4.00%)

Conference/Events
Hanson Wade to hold a virtual summit » 04:55
08/31/21
08/31
04:55
08/31/21
04:55
SANA

Sana Biotechnology

$23.88 /

-0.34 (-1.40%)

, ACET

Adicet Bio

$8.01 /

-0.07 (-0.87%)

, ACN

Accenture

$336.95 /

+1.1 (+0.33%)

, ADAP

Adaptimmune

$5.22 /

+0.065 (+1.26%)

, ALLO

Allogene Therapeutics

$24.14 /

-0.33 (-1.35%)

, AMGN

Amgen

$224.11 /

+1.29 (+0.58%)

, BMY

Bristol-Myers

$67.21 /

+0.61 (+0.92%)

, CDNA

CareDx

$80.47 /

+0.61 (+0.76%)

, CRBU

Caribou Biosciences

$24.56 /

-2.34 (-8.70%)

, CLLS

Cellectis

$13.99 /

-0.21 (-1.48%)

, TALS

Talaris Therapeutics

$11.99 /

-0.99 (-7.63%)

, TAK

Takeda Pharmaceutical

$16.56 /

-0.085 (-0.51%)

, SYNH

Syneos Health

$93.58 /

+1.58 (+1.72%)

, SGMO

Sangamo

$9.88 /

-0.09 (-0.90%)

, RHHBY

Roche

$49.75 /

-0.28 (-0.56%)

, NVS

Novartis

$91.68 /

-0.345 (-0.37%)

, FATE

Fate Therapeutics

$71.73 /

-0.92 (-1.27%)

, GSK

GlaxoSmithKline

$40.92 /

+0.09 (+0.22%)

, JNJ

Johnson & Johnson

$173.67 /

+0.75 (+0.43%)

, LEGN

Legend Biotech

$38.01 /

-0.11 (-0.29%)

, MRK

Merck

$76.51 /

+0.22 (+0.29%)

, MRKR

Marker Therapeutics

$1.90 /

-0.03 (-1.55%)

6th Annual CAR-TCR…

6th Annual CAR-TCR Virtual Summit will be held on August 30-September 2.Webcast Link

ShowHide Related Items >><<
TALS Talaris Therapeutics
$11.99 /

-0.99 (-7.63%)

TAK Takeda Pharmaceutical
$16.56 /

-0.085 (-0.51%)

SYNH Syneos Health
$93.58 /

+1.58 (+1.72%)

SGMO Sangamo
$9.88 /

-0.09 (-0.90%)

SANA Sana Biotechnology
$23.88 /

-0.34 (-1.40%)

RHHBY Roche
$49.75 /

-0.28 (-0.56%)

NVS Novartis
$91.68 /

-0.345 (-0.37%)

MRKR Marker Therapeutics
$1.90 /

-0.03 (-1.55%)

MRK Merck
$76.51 /

+0.22 (+0.29%)

LEGN Legend Biotech
$38.01 /

-0.11 (-0.29%)

JNJ Johnson & Johnson
$173.67 /

+0.75 (+0.43%)

GSK GlaxoSmithKline
$40.92 /

+0.09 (+0.22%)

FATE Fate Therapeutics
$71.73 /

-0.92 (-1.27%)

CRBU Caribou Biosciences
$24.56 /

-2.34 (-8.70%)

CLLS Cellectis
$13.99 /

-0.21 (-1.48%)

CDNA CareDx
$80.47 /

+0.61 (+0.76%)

BMY Bristol-Myers
$67.21 /

+0.61 (+0.92%)

AMGN Amgen
$224.11 /

+1.29 (+0.58%)

ALLO Allogene Therapeutics
$24.14 /

-0.33 (-1.35%)

ADAP Adaptimmune
$5.22 /

+0.065 (+1.26%)

ACN Accenture
$336.95 /

+1.1 (+0.33%)

ACET Adicet Bio
$8.01 /

-0.07 (-0.87%)

SANA Sana Biotechnology
$23.88 /

-0.34 (-1.40%)

03/01/21 Morgan Stanley
Sana Biotechnology initiated with an Overweight at Morgan Stanley
03/01/21 JPMorgan
Sana Biotechnology initiated with a Neutral at JPMorgan
03/01/21 BofA
Sana Biotechnology initiated with a Buy at BofA
03/01/21 Goldman Sachs
Sana Biotechnology initiated with a Neutral at Goldman Sachs
ACET Adicet Bio
$8.01 /

-0.07 (-0.87%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
ACN Accenture
$336.95 /

+1.1 (+0.33%)

08/17/21 JPMorgan
Accenture price target raised to $364 from $308 at JPMorgan
07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
ADAP Adaptimmune
$5.22 /

+0.065 (+1.26%)

05/28/21 Barclays
Adaptimmune initiated with an Underweight at Barclays
ALLO Allogene Therapeutics
$24.14 /

-0.33 (-1.35%)

08/06/21 B. Riley
Allogene Therapeutics price target lowered to $40 from $52 at B. Riley
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
AMGN Amgen
$224.11 /

+1.29 (+0.58%)

08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
08/04/21 Piper Sandler
Amgen Q2 'good enough' to avoid share selloff, says Piper Sandler
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 SVB Leerink
Amgen price target raised to $238 from $230 at SVB Leerink
BMY Bristol-Myers
$67.21 /

+0.61 (+0.92%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
CDNA CareDx
$80.47 /

+0.61 (+0.76%)

07/30/21 Piper Sandler
CareDx price target raised to $110 from $100 at Piper Sandler
07/20/21
Fly Intel: Top five analyst initiations
07/20/21 BTIG
CareDx assumed with a Buy at BTIG
07/15/21 Craig-Hallum
CMS Billing and Coding document 'good news' for CareDx, says Craig-Hallum
CRBU Caribou Biosciences
$24.56 /

-2.34 (-8.70%)

08/17/21
Fly Intel: Top five analyst initiations
08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
CLLS Cellectis
$13.99 /

-0.21 (-1.48%)

04/28/21 Guggenheim
Cellectis downgraded to Neutral on slow progress at Guggenheim
04/28/21 Guggenheim
Cellectis downgraded to Neutral from Buy at Guggenheim
03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
TALS Talaris Therapeutics
$11.99 /

-0.99 (-7.63%)

06/01/21 SVB Leerink
Talaris Therapeutics initiated with an Outperform at SVB Leerink
06/01/21 Evercore ISI
Evercore starts Talaris Therapeutics at Outperform with $35 price target
06/01/21 Evercore ISI
Talaris Therapeutics initiated with an Outperform at Evercore ISI
06/01/21 Guggenheim
Talaris Therapeutics initiated with a Buy at Guggenheim
TAK Takeda Pharmaceutical
$16.56 /

-0.085 (-0.51%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
SYNH Syneos Health
$93.58 /

+1.58 (+1.72%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
SGMO Sangamo
$9.88 /

-0.09 (-0.90%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RHHBY Roche
$49.75 /

-0.28 (-0.56%)

08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
07/23/21 Barclays
Roche price target raised to CHF 395 from CHF 375 at Barclays
07/22/21 UBS
Roche price target raised to CHF 375 from CHF 330 at UBS
NVS Novartis
$91.68 /

-0.345 (-0.37%)

07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/22/21 Deutsche Bank
Novartis downgraded to Hold from Buy at Deutsche Bank
07/12/21 SVB Leerink
Molecular Partners assumed with an Outperform at SVB Leerink
FATE Fate Therapeutics
$71.73 /

-0.92 (-1.27%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
GSK GlaxoSmithKline
$40.92 /

+0.09 (+0.22%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
08/18/21 Wedbush
AnaptysBio price target raised to $25 from $20 at Wedbush
JNJ Johnson & Johnson
$173.67 /

+0.75 (+0.43%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
LEGN Legend Biotech
$38.01 /

-0.11 (-0.29%)

06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
MRK Merck
$76.51 /

+0.22 (+0.29%)

08/25/21 H.C. Wainwright
Ligand gets royalty on sales of Merck's Vaxneuvance, says H.C. Wainwright
07/26/21 Truist
Merck assumed with a Buy at Truist
07/26/21 Truist
Merck assumed with a Buy at Truist
07/02/21 Mizuho
Merck gastric cancer withdrawal not meaningful, says Mizuho
MRKR Marker Therapeutics
$1.90 /

-0.03 (-1.55%)

03/25/21 Piper Sandler
Marker Therapeutics initiated with an Overweight at Piper Sandler
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Cantor Fitzgerald
Cantor Fitzgerald starts 'undervalued' Marker Therapeutics at Overweight
03/18/21 Cantor Fitzgerald
Marker Therapeutics initiated with an Overweight at Cantor Fitzgerald
TALS Talaris Therapeutics
$11.99 /

-0.99 (-7.63%)

TAK Takeda Pharmaceutical
$16.56 /

-0.085 (-0.51%)

SYNH Syneos Health
$93.58 /

+1.58 (+1.72%)

SGMO Sangamo
$9.88 /

-0.09 (-0.90%)

SANA Sana Biotechnology
$23.88 /

-0.34 (-1.40%)

RHHBY Roche
$49.75 /

-0.28 (-0.56%)

NVS Novartis
$91.68 /

-0.345 (-0.37%)

MRKR Marker Therapeutics
$1.90 /

-0.03 (-1.55%)

MRK Merck
$76.51 /

+0.22 (+0.29%)

LEGN Legend Biotech
$38.01 /

-0.11 (-0.29%)

JNJ Johnson & Johnson
$173.67 /

+0.75 (+0.43%)

GSK GlaxoSmithKline
$40.92 /

+0.09 (+0.22%)

FATE Fate Therapeutics
$71.73 /

-0.92 (-1.27%)

CLLS Cellectis
$13.99 /

-0.21 (-1.48%)

CDNA CareDx
$80.47 /

+0.61 (+0.76%)

BMY Bristol-Myers
$67.21 /

+0.61 (+0.92%)

AMGN Amgen
$224.11 /

+1.29 (+0.58%)

ALLO Allogene Therapeutics
$24.14 /

-0.33 (-1.35%)

ADAP Adaptimmune
$5.22 /

+0.065 (+1.26%)

ACN Accenture
$336.95 /

+1.1 (+0.33%)

ACET Adicet Bio
$8.01 /

-0.07 (-0.87%)

  • 23
    Jul
  • 03
    Jun
  • 04
    May
  • 07
    May
  • 12
    Mar
  • 01
    Mar
  • 10
    Feb
  • 04
    Feb
  • 21
    Jan
  • 06
    Jan
  • 16
    Dec
  • 02
    Dec
  • 24
    Sep
  • 16
    Sep
TAK Takeda Pharmaceutical
$16.56 /

-0.085 (-0.51%)

SYNH Syneos Health
$93.58 /

+1.58 (+1.72%)

RHHBY Roche
$49.75 /

-0.28 (-0.56%)

NVS Novartis
$91.68 /

-0.345 (-0.37%)

MRK Merck
$76.51 /

+0.22 (+0.29%)

JNJ Johnson & Johnson
$173.67 /

+0.75 (+0.43%)

GSK GlaxoSmithKline
$40.92 /

+0.09 (+0.22%)

BMY Bristol-Myers
$67.21 /

+0.61 (+0.92%)

ACN Accenture
$336.95 /

+1.1 (+0.33%)

TALS Talaris Therapeutics
$11.99 /

-0.99 (-7.63%)

TAK Takeda Pharmaceutical
$16.56 /

-0.085 (-0.51%)

RHHBY Roche
$49.75 /

-0.28 (-0.56%)

NVS Novartis
$91.68 /

-0.345 (-0.37%)

MRKR Marker Therapeutics
$1.90 /

-0.03 (-1.55%)

MRK Merck
$76.51 /

+0.22 (+0.29%)

LEGN Legend Biotech
$38.01 /

-0.11 (-0.29%)

JNJ Johnson & Johnson
$173.67 /

+0.75 (+0.43%)

GSK GlaxoSmithKline
$40.92 /

+0.09 (+0.22%)

FATE Fate Therapeutics
$71.73 /

-0.92 (-1.27%)

CRBU Caribou Biosciences
$24.56 /

-2.34 (-8.70%)

CDNA CareDx
$80.47 /

+0.61 (+0.76%)

BMY Bristol-Myers
$67.21 /

+0.61 (+0.92%)

AMGN Amgen
$224.11 /

+1.29 (+0.58%)

ALLO Allogene Therapeutics
$24.14 /

-0.33 (-1.35%)

ADAP Adaptimmune
$5.22 /

+0.065 (+1.26%)

ACN Accenture
$336.95 /

+1.1 (+0.33%)

ACET Adicet Bio
$8.01 /

-0.07 (-0.87%)

TAK Takeda Pharmaceutical
$16.56 /

-0.085 (-0.51%)

SANA Sana Biotechnology
$23.88 /

-0.34 (-1.40%)

MRK Merck
$76.51 /

+0.22 (+0.29%)

JNJ Johnson & Johnson
$173.67 /

+0.75 (+0.43%)

GSK GlaxoSmithKline
$40.92 /

+0.09 (+0.22%)

BMY Bristol-Myers
$67.21 /

+0.61 (+0.92%)

AMGN Amgen
$224.11 /

+1.29 (+0.58%)

ACN Accenture
$336.95 /

+1.1 (+0.33%)

ACET Adicet Bio
$8.01 /

-0.07 (-0.87%)

Conference/Events
Hanson Wade to hold a virtual summit » 09:34
08/30/21
08/30
09:34
08/30/21
09:34
SANA

Sana Biotechnology

$24.21 /

+1.46 (+6.42%)

, ACET

Adicet Bio

$8.04 /

+0.34 (+4.42%)

, ACN

Accenture

$335.87 /

+2.74 (+0.82%)

, ADAP

Adaptimmune

$5.16 /

+0.105 (+2.08%)

, ALLO

Allogene Therapeutics

$24.39 /

+0.7 (+2.95%)

, AMGN

Amgen

$222.75 /

+1.32 (+0.60%)

, BMY

Bristol-Myers

$66.60 /

-0.4 (-0.60%)

, CDNA

CareDx

$79.86 /

+2.61 (+3.38%)

, CRBU

Caribou Biosciences

$26.90 /

-0.11 (-0.41%)

, CLLS

Cellectis

$14.18 /

+0.685 (+5.08%)

, TALS

Talaris Therapeutics

$12.98 /

+0.63 (+5.10%)

, TAK

Takeda Pharmaceutical

$16.64 /

-0.05 (-0.30%)

, SYNH

Syneos Health

$91.99 /

+0.84 (+0.92%)

, SGMO

Sangamo

$9.98 /

+0.33 (+3.42%)

, RHHBY

Roche

$50.03 /

+0.39 (+0.79%)

, NVS

Novartis

$92.02 /

+0.49 (+0.54%)

, FATE

Fate Therapeutics

$72.52 /

+1.22 (+1.71%)

, GSK

GlaxoSmithKline

$40.83 /

-0.11 (-0.27%)

, JNJ

Johnson & Johnson

$172.92 /

-0.38 (-0.22%)

, LEGN

Legend Biotech

$38.12 /

+1.235 (+3.35%)

, MRK

Merck

$76.29 /

-0.26 (-0.34%)

, MRKR

Marker Therapeutics

$1.93 /

+0.07 (+3.76%)

6th Annual CAR-TCR…

6th Annual CAR-TCR Virtual Summit will be held on August 30-September 2.Webcast Link

ShowHide Related Items >><<
TALS Talaris Therapeutics
$12.98 /

+0.63 (+5.10%)

TAK Takeda Pharmaceutical
$16.64 /

-0.05 (-0.30%)

SYNH Syneos Health
$91.99 /

+0.84 (+0.92%)

SGMO Sangamo
$9.98 /

+0.33 (+3.42%)

SANA Sana Biotechnology
$24.21 /

+1.46 (+6.42%)

RHHBY Roche
$50.03 /

+0.39 (+0.79%)

NVS Novartis
$92.02 /

+0.49 (+0.54%)

MRKR Marker Therapeutics
$1.93 /

+0.07 (+3.76%)

MRK Merck
$76.29 /

-0.26 (-0.34%)

LEGN Legend Biotech
$38.12 /

+1.235 (+3.35%)

JNJ Johnson & Johnson
$172.92 /

-0.38 (-0.22%)

GSK GlaxoSmithKline
$40.83 /

-0.11 (-0.27%)

FATE Fate Therapeutics
$72.52 /

+1.22 (+1.71%)

CRBU Caribou Biosciences
$26.90 /

-0.11 (-0.41%)

CLLS Cellectis
$14.18 /

+0.685 (+5.08%)

CDNA CareDx
$79.86 /

+2.61 (+3.38%)

BMY Bristol-Myers
$66.60 /

-0.4 (-0.60%)

AMGN Amgen
$222.75 /

+1.32 (+0.60%)

ALLO Allogene Therapeutics
$24.39 /

+0.7 (+2.95%)

ADAP Adaptimmune
$5.16 /

+0.105 (+2.08%)

ACN Accenture
$335.87 /

+2.74 (+0.82%)

ACET Adicet Bio
$8.04 /

+0.34 (+4.42%)

SANA Sana Biotechnology
$24.21 /

+1.46 (+6.42%)

03/01/21 Morgan Stanley
Sana Biotechnology initiated with an Overweight at Morgan Stanley
03/01/21 JPMorgan
Sana Biotechnology initiated with a Neutral at JPMorgan
03/01/21 BofA
Sana Biotechnology initiated with a Buy at BofA
03/01/21 Goldman Sachs
Sana Biotechnology initiated with a Neutral at Goldman Sachs
ACET Adicet Bio
$8.04 /

+0.34 (+4.42%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
ACN Accenture
$335.87 /

+2.74 (+0.82%)

08/17/21 JPMorgan
Accenture price target raised to $364 from $308 at JPMorgan
07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
ADAP Adaptimmune
$5.16 /

+0.105 (+2.08%)

05/28/21 Barclays
Adaptimmune initiated with an Underweight at Barclays
ALLO Allogene Therapeutics
$24.39 /

+0.7 (+2.95%)

08/06/21 B. Riley
Allogene Therapeutics price target lowered to $40 from $52 at B. Riley
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
AMGN Amgen
$222.75 /

+1.32 (+0.60%)

08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
08/04/21 Piper Sandler
Amgen Q2 'good enough' to avoid share selloff, says Piper Sandler
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 SVB Leerink
Amgen price target raised to $238 from $230 at SVB Leerink
BMY Bristol-Myers
$66.60 /

-0.4 (-0.60%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
CDNA CareDx
$79.86 /

+2.61 (+3.38%)

07/30/21 Piper Sandler
CareDx price target raised to $110 from $100 at Piper Sandler
07/20/21
Fly Intel: Top five analyst initiations
07/20/21 BTIG
CareDx assumed with a Buy at BTIG
07/15/21 Craig-Hallum
CMS Billing and Coding document 'good news' for CareDx, says Craig-Hallum
CRBU Caribou Biosciences
$26.90 /

-0.11 (-0.41%)

08/17/21
Fly Intel: Top five analyst initiations
08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
CLLS Cellectis
$14.18 /

+0.685 (+5.08%)

04/28/21 Guggenheim
Cellectis downgraded to Neutral on slow progress at Guggenheim
04/28/21 Guggenheim
Cellectis downgraded to Neutral from Buy at Guggenheim
03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
TALS Talaris Therapeutics
$12.98 /

+0.63 (+5.10%)

06/01/21 SVB Leerink
Talaris Therapeutics initiated with an Outperform at SVB Leerink
06/01/21 Evercore ISI
Evercore starts Talaris Therapeutics at Outperform with $35 price target
06/01/21 Evercore ISI
Talaris Therapeutics initiated with an Outperform at Evercore ISI
06/01/21 Guggenheim
Talaris Therapeutics initiated with a Buy at Guggenheim
TAK Takeda Pharmaceutical
$16.64 /

-0.05 (-0.30%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
SYNH Syneos Health
$91.99 /

+0.84 (+0.92%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
SGMO Sangamo
$9.98 /

+0.33 (+3.42%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RHHBY Roche
$50.03 /

+0.39 (+0.79%)

08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
07/23/21 Barclays
Roche price target raised to CHF 395 from CHF 375 at Barclays
07/22/21 UBS
Roche price target raised to CHF 375 from CHF 330 at UBS
NVS Novartis
$92.02 /

+0.49 (+0.54%)

07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/22/21 Deutsche Bank
Novartis downgraded to Hold from Buy at Deutsche Bank
07/12/21 SVB Leerink
Molecular Partners assumed with an Outperform at SVB Leerink
FATE Fate Therapeutics
$72.52 /

+1.22 (+1.71%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
GSK GlaxoSmithKline
$40.83 /

-0.11 (-0.27%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
08/18/21 Wedbush
AnaptysBio price target raised to $25 from $20 at Wedbush
JNJ Johnson & Johnson
$172.92 /

-0.38 (-0.22%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
LEGN Legend Biotech
$38.12 /

+1.235 (+3.35%)

06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
MRK Merck
$76.29 /

-0.26 (-0.34%)

08/25/21 H.C. Wainwright
Ligand gets royalty on sales of Merck's Vaxneuvance, says H.C. Wainwright
07/26/21 Truist
Merck assumed with a Buy at Truist
07/26/21 Truist
Merck assumed with a Buy at Truist
07/02/21 Mizuho
Merck gastric cancer withdrawal not meaningful, says Mizuho
MRKR Marker Therapeutics
$1.93 /

+0.07 (+3.76%)

03/25/21 Piper Sandler
Marker Therapeutics initiated with an Overweight at Piper Sandler
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Cantor Fitzgerald
Cantor Fitzgerald starts 'undervalued' Marker Therapeutics at Overweight
03/18/21 Cantor Fitzgerald
Marker Therapeutics initiated with an Overweight at Cantor Fitzgerald
TALS Talaris Therapeutics
$12.98 /

+0.63 (+5.10%)

TAK Takeda Pharmaceutical
$16.64 /

-0.05 (-0.30%)

SYNH Syneos Health
$91.99 /

+0.84 (+0.92%)

SGMO Sangamo
$9.98 /

+0.33 (+3.42%)

SANA Sana Biotechnology
$24.21 /

+1.46 (+6.42%)

RHHBY Roche
$50.03 /

+0.39 (+0.79%)

NVS Novartis
$92.02 /

+0.49 (+0.54%)

MRKR Marker Therapeutics
$1.93 /

+0.07 (+3.76%)

MRK Merck
$76.29 /

-0.26 (-0.34%)

LEGN Legend Biotech
$38.12 /

+1.235 (+3.35%)

JNJ Johnson & Johnson
$172.92 /

-0.38 (-0.22%)

GSK GlaxoSmithKline
$40.83 /

-0.11 (-0.27%)

FATE Fate Therapeutics
$72.52 /

+1.22 (+1.71%)

CLLS Cellectis
$14.18 /

+0.685 (+5.08%)

CDNA CareDx
$79.86 /

+2.61 (+3.38%)

BMY Bristol-Myers
$66.60 /

-0.4 (-0.60%)

AMGN Amgen
$222.75 /

+1.32 (+0.60%)

ALLO Allogene Therapeutics
$24.39 /

+0.7 (+2.95%)

ADAP Adaptimmune
$5.16 /

+0.105 (+2.08%)

ACN Accenture
$335.87 /

+2.74 (+0.82%)

ACET Adicet Bio
$8.04 /

+0.34 (+4.42%)

  • 23
    Jul
  • 03
    Jun
  • 04
    May
  • 07
    May
  • 12
    Mar
  • 01
    Mar
  • 10
    Feb
  • 04
    Feb
  • 21
    Jan
  • 06
    Jan
  • 16
    Dec
  • 02
    Dec
  • 24
    Sep
  • 16
    Sep
TAK Takeda Pharmaceutical
$16.64 /

-0.05 (-0.30%)

SYNH Syneos Health
$91.99 /

+0.84 (+0.92%)

RHHBY Roche
$50.03 /

+0.39 (+0.79%)

NVS Novartis
$92.02 /

+0.49 (+0.54%)

MRK Merck
$76.29 /

-0.26 (-0.34%)

JNJ Johnson & Johnson
$172.92 /

-0.38 (-0.22%)

GSK GlaxoSmithKline
$40.83 /

-0.11 (-0.27%)

BMY Bristol-Myers
$66.60 /

-0.4 (-0.60%)

ACN Accenture
$335.87 /

+2.74 (+0.82%)

TALS Talaris Therapeutics
$12.98 /

+0.63 (+5.10%)

TAK Takeda Pharmaceutical
$16.64 /

-0.05 (-0.30%)

RHHBY Roche
$50.03 /

+0.39 (+0.79%)

NVS Novartis
$92.02 /

+0.49 (+0.54%)

MRKR Marker Therapeutics
$1.93 /

+0.07 (+3.76%)

MRK Merck
$76.29 /

-0.26 (-0.34%)

LEGN Legend Biotech
$38.12 /

+1.235 (+3.35%)

JNJ Johnson & Johnson
$172.92 /

-0.38 (-0.22%)

GSK GlaxoSmithKline
$40.83 /

-0.11 (-0.27%)

FATE Fate Therapeutics
$72.52 /

+1.22 (+1.71%)

CRBU Caribou Biosciences
$26.90 /

-0.11 (-0.41%)

CDNA CareDx
$79.86 /

+2.61 (+3.38%)

BMY Bristol-Myers
$66.60 /

-0.4 (-0.60%)

AMGN Amgen
$222.75 /

+1.32 (+0.60%)

ALLO Allogene Therapeutics
$24.39 /

+0.7 (+2.95%)

ADAP Adaptimmune
$5.16 /

+0.105 (+2.08%)

ACN Accenture
$335.87 /

+2.74 (+0.82%)

ACET Adicet Bio
$8.04 /

+0.34 (+4.42%)

TAK Takeda Pharmaceutical
$16.64 /

-0.05 (-0.30%)

SANA Sana Biotechnology
$24.21 /

+1.46 (+6.42%)

MRK Merck
$76.29 /

-0.26 (-0.34%)

JNJ Johnson & Johnson
$172.92 /

-0.38 (-0.22%)

GSK GlaxoSmithKline
$40.83 /

-0.11 (-0.27%)

BMY Bristol-Myers
$66.60 /

-0.4 (-0.60%)

AMGN Amgen
$222.75 /

+1.32 (+0.60%)

ACN Accenture
$335.87 /

+2.74 (+0.82%)

ACET Adicet Bio
$8.04 /

+0.34 (+4.42%)

Over a month ago
Initiation
Fly Intel: Top five analyst initiations » 09:56
08/17/21
08/17
09:56
08/17/21
09:56
CTKB

Cytek Biosciences

$23.13 /

+0.13 (+0.57%)

, GAMB

Gambling.com

$7.65 /

+0.1 (+1.32%)

, OB

Outbrain

$19.19 /

+ (+0.00%)

, SOPH

Sophia Genetics

$18.15 /

+0.15 (+0.83%)

, CRBU

Caribou Biosciences

$26.70 /

+0.21 (+0.79%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cytek Biosciences (CTKB) initiated with an Overweight at Piper Sandler. 2. Gambling.com (GAMB) initiated with a Buy at Truist, Stifel and Jefferies. 3. Outbrain (OB) initiated with a Buy at Citi, and Needham, initiated with an Outperform at JMP Securities, and Evercore ISI and initiated with a Hold at Jefferies. 4. Sophia Genetics (SOPH) initiated with an Overweight at JPMorgan and an Outperform at Cowen. 5. Caribou Biosciences (CRBU) initiated with a Buy at BofA, a Neutral at Citi and an Outperform at SVB Leerink. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
OB Outbrain
$19.19 /

+ (+0.00%)

CRBU Caribou Biosciences
$26.70 /

+0.21 (+0.79%)

CTKB Cytek Biosciences
$23.13 /

+0.13 (+0.57%)

08/17/21 Morgan Stanley
Cytek Biosciences initiated with an Equal Weight at Morgan Stanley
08/17/21 Goldman Sachs
Cytek Biosciences initiated with a Buy at Goldman Sachs
08/17/21 Piper Sandler
Cytek Biosciences initiated with an Overweight at Piper Sandler
GAMB Gambling.com
$7.65 /

+0.1 (+1.32%)

08/17/21 Truist
Gambling.com initiated with a Buy at Truist
08/17/21 Jefferies
Gambling.com initiated with a Buy at Jefferies
08/17/21 Stifel
Stifel starts Gambling.com at Buy with $10 price target
08/17/21 Stifel
Gambling.com initiated with a Buy at Stifel
OB Outbrain
$19.19 /

+ (+0.00%)

08/17/21 Jefferies
Jefferies starts Outbrain at Hold, favors other digital ad names
08/17/21 Evercore ISI
Evercore ISI starts Outbrain at Outperform with $25 price target
08/17/21 Evercore ISI
Outbrain initiated with an Outperform at Evercore ISI
08/17/21 Jefferies
Outbrain initiated with a Hold at Jefferies
SOPH Sophia Genetics
$18.15 /

+0.15 (+0.83%)

08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
08/17/21 Morgan Stanley
Morgan Stanley starts Sophia Genetics at Overweight with $24 price target
08/17/21 Cowen
Sophia Genetics initiated with an Outperform at Cowen
08/17/21 JPMorgan
Sophia Genetics initiated with an Overweight at JPMorgan
CRBU Caribou Biosciences
$26.70 /

+0.21 (+0.79%)

08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
08/17/21 BofA
Caribou Biosciences initiated with a Buy at BofA
  • 23
    Jul
  • 23
    Jul
  • 23
    Jul
  • 23
    Jul
  • 23
    Jul
GAMB Gambling.com
$7.65 /

+0.1 (+1.32%)

CTKB Cytek Biosciences
$23.13 /

+0.13 (+0.57%)

Initiation
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform » 08:48
08/17/21
08/17
08:48
08/17/21
08:48
CRBU

Caribou Biosciences

$26.49 /

+2.31 (+9.55%)

As previously reported,…

As previously reported, SVB Leerink analyst Mani Foroohar initiated coverage of Caribou Biosciences with an Outperform rating and $32 price target. The analyst notes that Caribou's proprietary CRISPR-based platform utilizing hybrid RNA-DNA guides offers potential for meaningful differentiation versus competitors, with evidence for greater editing specificity and insertion efficacy especially appealing when multiple edits/insertions are needed in a cell therapy product.

ShowHide Related Items >><<
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
08/17/21 BofA
Caribou Biosciences initiated with a Buy at BofA
08/17/21 Citi
Caribou Biosciences initiated with a Neutral at Citi
  • 23
    Jul
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

Initiation
Caribou Biosciences initiated with an Outperform at SVB Leerink » 08:10
08/17/21
08/17
08:10
08/17/21
08:10
CRBU

Caribou Biosciences

$26.49 /

+2.31 (+9.55%)

SVB Leerink analyst Mani…

SVB Leerink analyst Mani Foroohar initiated coverage of Caribou Biosciences with an Outperform rating and $32 price target.

ShowHide Related Items >><<
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
08/17/21 BofA
Caribou Biosciences initiated with a Buy at BofA
08/17/21 Citi
Caribou Biosciences initiated with a Neutral at Citi
  • 23
    Jul
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

Initiation
BofA starts Caribou Biosciences at Buy with $30 price target » 07:37
08/17/21
08/17
07:37
08/17/21
07:37
CRBU

Caribou Biosciences

$26.49 /

+2.31 (+9.55%)

As previously reported,…

As previously reported, BofA analyst Geoff Meacham initiated coverage of Caribou Biosciences with a Buy rating and $30 price target. What sets Caribou apart from other clinical-stage biotech companies developing allogeneic CAR-T therapies is its novel CRISPR-Cas gene editing technology called chRDNA and pronounced "chardonnay," Meacham tells investors. The chRDNA technology improves on first generation gene-editing technologies in terms of efficiency, specificity, ability to make multiple edits, and ease of use, said Meacham, who sees initial clinical data over 2022 being "the biggest event triggering a value inflection."

ShowHide Related Items >><<
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

08/17/21 BofA
Caribou Biosciences initiated with a Buy at BofA
08/17/21 Citi
Caribou Biosciences initiated with a Neutral at Citi
  • 23
    Jul
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

Initiation
Caribou Biosciences initiated with a Buy at BofA » 06:09
08/17/21
08/17
06:09
08/17/21
06:09
CRBU

Caribou Biosciences

$26.49 /

+2.31 (+9.55%)

BofA initiated coverage…

BofA initiated coverage of Caribou Biosciences with a Buy rating and $30 price target.

ShowHide Related Items >><<
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

08/17/21 Citi
Caribou Biosciences initiated with a Neutral at Citi
  • 23
    Jul
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

Initiation
Caribou Biosciences initiated with a Neutral at Citi » 05:54
08/17/21
08/17
05:54
08/17/21
05:54
CRBU

Caribou Biosciences

$26.49 /

+2.31 (+9.55%)

Citi analyst Yigal…

Citi analyst Yigal Nochomovitz initiated coverage of Caribou Biosciences with a Neutral rating and $27 price target. Caribou is an "exciting new entrant" to the gene editing space featuring the novel chRDNA platform as the company's core innovation, Nochomovitz tells investors in a research note. However, with the stock up 65% since the initial public offering, the analyst views the current valuation as fair.

ShowHide Related Items >><<
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

  • 23
    Jul
CRBU Caribou Biosciences
$26.49 /

+2.31 (+9.55%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.